153 related articles for article (PubMed ID: 8363380)
1. Biliary excretion of cefixime: assessment in patients provided with T-tube drainage.
Westphal JF; Jehl F; Schloegel M; Monteil H; Brogard JM
Antimicrob Agents Chemother; 1993 Jul; 37(7):1488-91. PubMed ID: 8363380
[TBL] [Abstract][Full Text] [Related]
2. Role of intrahepatic protein binding in the hepatobiliary extraction profile of cefixime in humans.
Westphal JF; Jehl F; Adloff M; Brogard JM
Clin Pharmacol Ther; 1993 Nov; 54(5):476-84. PubMed ID: 8222490
[TBL] [Abstract][Full Text] [Related]
3. [Biliary excretion and hepatic disposal of cefixime: experimental and clinical study].
Westphal JF; Brogard JM; Jehl F; Blickle JF; Dorner M; Monteil H
Pathol Biol (Paris); 1992 May; 40(5):538-44. PubMed ID: 1495841
[TBL] [Abstract][Full Text] [Related]
4. [Kinetics of cefixime biliary clearance in cholecystectomized patients].
Westphal JF; Jehl F; Brogard JM
Therapie; 1994; 49(1):35-9. PubMed ID: 8091363
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cefixime biliary disposition in the isolated perfused rabbit liver model and in humans.
Westphal JF; Brogard JM; Jehl F; Schloegel M; Blickle JF; Monteil H
Drugs Exp Clin Res; 1992; 18(8):329-36. PubMed ID: 1292915
[TBL] [Abstract][Full Text] [Related]
6. Concentration of cefixime in bile, gallbladder wall and serum after preoperative administration in patients undergoing cholecystectomy.
Moorthi K; Fleckenstein G; Nies B
Methods Find Exp Clin Pharmacol; 1990 May; 12(4):287-90. PubMed ID: 2374476
[TBL] [Abstract][Full Text] [Related]
7. Biliary excretion of ceftizoxime in humans.
Brogard JM; Arnaud JP; Timmler R
Chemotherapy; 1984; 30(4):221-6. PubMed ID: 6086245
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
Kees F; Naber KG
Infection; 1990; 18 Suppl 3():S150-4. PubMed ID: 2079377
[TBL] [Abstract][Full Text] [Related]
9. Effect of ursodeoxycholate on the biliary excretion of cefotiam and sulbenicillin in patients with percutaneous transhepatic biliary drainage.
Higashi K; Hayakawa T; Katagiri K; Tsukada K; Ito K; Hoshino M; Miyaji M; Takeuchi T; Yamamoto T
Antimicrob Agents Chemother; 1988 May; 32(5):726-9. PubMed ID: 3164988
[TBL] [Abstract][Full Text] [Related]
10. Alternative continuous infusion method for analysis of enterohepatic circulation and biliary excretion of cefixime in the rat.
Yasui H; Yamaoka K; Nakagawa T
J Pharm Sci; 1994 Jun; 83(6):819-23. PubMed ID: 9120813
[TBL] [Abstract][Full Text] [Related]
11. Biliary excretion of rufloxacin in humans.
Privitera G; Nicastro G; Imbimbo BP; Cesana M; Visconti M; Lombardi F; Tagliabue G; Faleschini E; Colturani F; Franzini P
Antimicrob Agents Chemother; 1993 Dec; 37(12):2545-9. PubMed ID: 8109915
[TBL] [Abstract][Full Text] [Related]
12. Biliary tract excretion of ofloxacin in man.
Kazmierczak A; Pechinot A; Duez JM; Haas O; Favre JP
Drugs; 1987; 34 Suppl 1():39-43. PubMed ID: 3481327
[TBL] [Abstract][Full Text] [Related]
13. Biliary elimination of cefotiam, an experimental and clinical study.
Brogard JM; Arnaud JP; Blickle JF; Levy P; Dorner M; Lautier F
Chemotherapy; 1986; 32(3):222-35. PubMed ID: 3458565
[TBL] [Abstract][Full Text] [Related]
14. Hepatobiliary kinetics and excretion of ciprofloxacin.
Parry MF; Smego DA; Digiovanni MA
Antimicrob Agents Chemother; 1988 Jul; 32(7):982-5. PubMed ID: 3190199
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
Mamzoridi K; Kasteridou N; Peonides A; Niopas I
Pharmacol Toxicol; 1996 Jun; 78(6):417-20. PubMed ID: 8829204
[TBL] [Abstract][Full Text] [Related]
16. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.
Ratzan KR; Ruiz C; Irvin GL
Antimicrob Agents Chemother; 1974 Oct; 6(4):426-31. PubMed ID: 4157339
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary elimination of temafloxacin.
Sörgel F; Granneman GR; Mahr G; Kujath P; Fabian W; Nickel P
Clin Pharmacokinet; 1992; 22 Suppl 1():33-42. PubMed ID: 1319869
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children.
Nahata MC; Kohlbrenner VM; Barson WJ
Chemotherapy; 1993; 39(1):1-5. PubMed ID: 8444056
[TBL] [Abstract][Full Text] [Related]
19. Cefixime, in-vitro activity, pharmacokinetics and tissue penetration.
Stone JW; Linong G; Andrews JM; Wise R
J Antimicrob Chemother; 1989 Feb; 23(2):221-8. PubMed ID: 2708180
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacologic aspects of cefixime in dogs.
Lavy E; Ziv G; Aroch I; Glickman A
Am J Vet Res; 1995 May; 56(5):633-8. PubMed ID: 7661460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
